MAPT and Mental deterioration: We chose this marker rather than examining Aβ and tau biomarkers individually because the ratio captures the interplay between Aβ and tau pathologies and this interplay is more closely tied to disease progression and cognitive decline [20–22] and shows critical sex differences [4].